Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > ATM

<< Previous

Bullboard Posts

Next >>

Comment by Azzak34on Feb 21, 2024 6:00pm

103 Views

Post# 35892015

RE:RE:RE:RE:RE:RE:RE:RE:ATM

Yeah patients living longer in oncology trials is terrible news.

Everyone has clearly stated their discontent and disapproval of the board thus far. I have also commented as much. The company has certainly not engendered itself to its shareholders, they have done a poor job with development and a worse job with communication. However, the results have been very strong and the board is stacked with beasts. Our advisors are also monsters so I'm still very happy that the people who actually have shares, will make an absolute fortune.

Or you could invest in Crisper and see how much unicorn semen they can sell before the bottom drops out.

<< Previous

Bullboard Posts

Next >>

Ivanhoe Mines initiates Phase 3 concentrator construction